Pharma & Biotech

Inari Medical Inc. and several of its former executives are mounting a vigorous defense against a class action lawsuit filed...

While 89bio continues to advance its key Phase 3 trial for its flagship drug candidate, Pegozafermin, the company has received...

Eli Lilly has generated significant attention in oncology circles following the FDA's decision to grant its lung cancer treatment Olomorasib...

BioNTech SE has achieved a significant milestone in its oncology pipeline, sending its stock price sharply higher. The Mainz-based biotechnology...

Shares of Rapid Micro Biosystems have staged an impressive three-day rally, defying conventional market logic after the company reported disappointing...

The investment case for Edwards Lifesciences presents a fascinating dichotomy as the company strengthens its strategic position while facing concerning...

Northwest Biotherapeutics shares closed lower for the fourth straight trading day, declining by 3.42% to settle at $0.251. The session...

What separates a promising biotech company from a true market leader? Halozyme Therapeutics is providing a compelling case study with...

A notable surge in Cabaletta Bio's stock price on Friday has captured investor attention, with shares climbing over 10%. The...

While major indices closed relatively flat on Friday, significant strategic developments were unfolding at Zimmer Biomet Holdings, Inc. The medical...